Search

Your search keyword '"Gligic, Branko"' showing total 39 results
Start Over Author "Gligic, Branko"
39 results on '"Gligic, Branko"'

5. Impact of heart myxoma localization upon its clinical course and outcome

Author

Rafajlovski, Saso, primary, Ilic, Radoje, additional, Gligic, Branko, additional, Kanjuh, Vladimir, additional, Tatic, Vujadin, additional, Ristic, Andjelka, additional, Obradovic, Slobodan, additional, Dincic, Dragan, additional, Ratkovic, Nenad, additional, Romanovic, Radoslav, additional, Karic, Jasna, additional, Djenic, Nemanja, additional, and Vukotic, Snjezana, additional

Published
2012
Full Text
View/download PDF

8. Diagnosis and results of treatment of heart myxoma

Author

Rafajlovski, Saso, primary, Ilic, Radoje, additional, Gligic, Branko, additional, Kanjuh, Vladimir, additional, Tatic, Vujadin, additional, Ristic, Andjelka, additional, Obradovic, Slobodan, additional, Matunovic, Radomir, additional, and Prcovic, Biljana, additional

Published
2011
Full Text
View/download PDF

11. Changes in platelets and anticoagulant protein activity during adenosine-exercise single-photon emission computed tomography stress test

Author

Obradovic, Slobodan, primary, Subota, Vesna, additional, Baskot, Branislav, additional, Dopudja, Marija, additional, Antonijevic, Nebojsa, additional, Djenic, Nemanja, additional, Vukotic, Snijezana, additional, Salinger, Sonja, additional, Jovelic, Aleksandra, additional, Mikovic, Danijela, additional, Antovic, Jovan, additional, Grdenic, Aleksandra, additional, and Gligic, Branko, additional

Published
2010
Full Text
View/download PDF

12. Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention

Author

Obradovic, Slobodan D, primary, Antovic, Jovan P, additional, Antonijevic, Nebojsa M, additional, Ratkovic, Nenad G, additional, Vojvodic, Danilo V, additional, Subota, Vesna S, additional, Gligic, Branko Lj, additional, Obradovic, Dragana V, additional, Marinkovic, Jelena M, additional, and Wallen, Håkan N, additional

Published
2009
Full Text
View/download PDF

14. Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: Quantum of initial necrosis is the key

Author

Obradovic, Slobodan, primary, Balint, Bela, additional, Romanovic, Radoslav, additional, Trifunovic, Zoran, additional, Rusovic, Sinisa, additional, Baskot, Branislav, additional, Dopudja, Marija, additional, Trifunovic, Gordana, additional, Rafajlovski, Saso, additional, Jung, Robert, additional, and Gligic, Branko, additional

Published
2009
Full Text
View/download PDF

15. Diagnostic significance of myocardial perfusion scintigraphy in identification and localization of culprit lesions in patients undergoing elective PTCA

Author

Baskot, Branislav, primary, Jankovic, Zoran, additional, Obradovic, Slobodan, additional, Rusovic, Sinisa, additional, Orozovic, Vjekoslav, additional, Gligic, Branko, additional, Jung, Robert, additional, Ivanovic, Vladimir, additional, Pavlovic, Miodrag, additional, and Ratkovic, Nenad, additional

Published
2008
Full Text
View/download PDF

16. Adenosine stress protocols for myocardial perfusion imaging

Author

Baskot, Branislav, primary, Obradovic, Slobodan, additional, Gligic, Branko, additional, Orozovic, Vjekoslav, additional, Ristic-Angelkov, Andjelka, additional, Romanovic, Radosav, additional, Jung, Robert, additional, Ivanovic, Vladimir, additional, Bikicki, Miroslav, additional, and Pavlovic, Miodrag, additional

Published
2008
Full Text
View/download PDF

25. Statins and stroke

Author

Obradovic, Dragana, primary, Gligic, Branko, additional, Obradovic, Slobodan, additional, Popovic, Smiljana, additional, Maksic, Jasmina, additional, and Vukotic, Natasa, additional

Published
2003
Full Text
View/download PDF

35. Statini i ishemijska bolest mozga.

Author

Obradovic, Dragana, Gligic, Branko, Obradovic, Slobodan, Popovic, Smiljana, Maksic, Jasmina, and Vukotic, Nataša

Published
2003

36. Prognoza i terapija stenoze aortne valvule.

Author

Ristic-Andelkov, Andelka, Gligic, Branko, Damnjanovic, Milorad, Milanovic, Jovanka, Matunovic, Radomir, and Obradovic, Slobodan

Subjects
*AORTIC stenosis, *AORTIC valve diseases, *DYSPNEA, *CLINICAL trials, *MEDICINE
Abstract

There is a long latent period in the clinical course of aortic valve stenosis in adults. Symptoms ussually occur in the case of critical stenosis, when aortic orifice area is under 0.7cm² (0.4 cm²/m²). In this study 78 patients with critical aortic valve stenosis were investigated. The first manifestation of the disease was dyspnea (78.2%), angina (52.5%), less often a syncope (34.6%), while 17.9% of patients were asymptomatic. Left ventricular systolic function was preserved in 77% of patients, while left ventricular dyastolic dysfunction occured in almost all the patients. In 42 patients (53.4%) aortic valve replacement was performed. Left ventricular systolic function improved in 88.1% of patients postoperativelly, as well as in patients with preoperativelly preserved or poor systolic function. Recovery was fast particularly during the first 6 postoperative months. After the surgery the improvement of the left ventricular dyastolic function was slower then systolic, particularly in patients with extreme hypertrophy of myocardium in whom the process of recovery might last several years. [ABSTRACT FROM AUTHOR]

Published
2003

37. Odnos QT disperzije i reperfuzije u akutnom infarktu miokarda.

Author

Gligic, Branko, Romanovic, Radoslav, Raden, Goran, Tavciovski, Dragan, Duran, Predrag, and Obradovic, Slohudan

Subjects
*MYOCARDIAL infarction, *LONG QT syndrome, *REPERFUSION, *TISSUE plasminogen activator, *ARRHYTHMIA
Abstract

Background. QT dispersion (QTd) represents the parameter of the expanded heterogeneity of myocard of ventricles. The aim of this study was to examine the dynamics of changes of QTd during the first 5 days of the acute myocardial infarction (AMI) in dependence to noninvasively estimated success of thrombolytic therapy. Methods. Thirty six patients with AMI were included in the study. All patients were treated with alteplaze according to rapid protocol. QTd (QTc max-QTc min) was measured immediately after the reception (0 min), after the thrombolytic therapy (90 min) and since the 2nd to the 5th day of the hospitalization. Reperfusion was estimated on the basis of electrocardiographic and biohumoral parameters. Results. In the group of 36 patients, 22 male and 11 female, both parameters of the reperfusion were not compatible in 3 patients. The other 23 patients had the reperfusion, while 10 patients did not have it. At the reception there was no significant difference of QTd between the group with reperfusion (79±34 ms) and the group without reperfusion (65±19 ms). After receiving alteplase, the average QTd in the group with reperfusion was 67±31 ms, which was not shorter in relation to the group without reperfusion (70±23 ms). Since the 2nd day of AMI, significantly smaller QTd in papatients with reperfusion was not registered compared with the patients without the reperfusion (54±17 vs. 73±20 ms), whereas since the 3rd day the difference became significant (46±16 vs. 87±24 ms). On the 4th day it was 43±12 vs. 78±21 ms, and on the 5th day it was 38±11 vs. 62±23 ms. On the 1st day significant difference of QTd between the groups with and without reperfusion was not registered in the group of patients with anterior AMI (0 min: 97±47 vs. 72±16: 90 min: : 68±47 vs. 72±20) whereas on the 2nd day it became statistically significant (51±15 vs... [ABSTRACT FROM AUTHOR]

Published
2003
Full Text
View/download PDF

38. Ispitivanje efikasnosti i bezbednosti farmakoloških testova opterečenja u nuklearnoj kardiologiji.

Author

Baškot, Branislav, Rafajlovski, Sašo, Ristić-Angelkov, Anđelka, Obradović, Slobodan, Gligic, Branko, Orozović, Vjekoslav, and Agbaba, Nikola

Subjects
*PHARMACOLOGY, *EXERCISE tests, *POSITRON emission tomography, *CARDIAC radionuclide imaging, *CORONARY disease, *TREADMILL exercise tests, *VASODILATORS, *ADENOSINES
Abstract

Background/Aim. Treadmill test combined with myocardial perfusion scintigraphy (MPS) is a commonly used technique in the assessment of coronary artery disease. Many patients who cannot adequately perform exercise stress testing may nevertheless undergo pharmacological tests, most commonly with the vasodilator agents (adenosine and dipyridamole), as well as the positive inotropic agent dobutamine. Patients undergoing vasodilators stress testing with either dipyridamole or adenosine also perform simultaneous low-intensity exercise. The aim of this study was to compare various pharmacological stress tests alone or in combination with low intensity exercise as preparation for MPS in reagard to incidence of adverse effects, quality of diagnostic image and the acquisition initial time. Methods. A total of 2 205 patients underwent pharmacological stress tests. Pharmacological stress test with adenosine was applied in 493 patients. In 405 of them we performed concomitant low level exercise (50 W) by bicycle ergometar (AdenoEX). In 88 of them we performed adenosine abbreviated protocol (AdenoSCAN). In 1 526 patients we performed pharmacological stress test with dipyridamole. In 871 of them we performed concomitant low level exercise (50 W) by bicycle ergometar (DipyEX), and in 775 we used only dipyridamole protocol (DipySCAN). In 186 patients we used pharmacological stress test with dobutamine. We followed side effects of adenosine, dipyiridamole and dobutamine, compared results between protocols with concomitant low level exercise and vasodilatators only. We also compared image quality, and suggested time of acquisition after stress test. Results. We found numerous side effects especially with adenosine, but these effects were short-lived and not required active interventions. Benefit with concomitant exercise in booth AdenoEX and DipyEX included decreased side effects (AdenoEX vs AdenoSCAN 62% vs 87%, respectively, and DipyEX vs DipySCAN 37% vs 59%, respectively) improved safety and patients tolerance, improved target-to-background ratios because of less subdiaphragmal activity, and earlier acquisition time. Because of producing a lot of arrhythmias (in 49% of patients) dobutamin was considered a last choice for pharmacological stress testing. Conclusion. Safety and efficacy of vasodilatators (adenosine, dipyridamole) pharmacological stress tests are good, but with concomitant exercise even better. The safety and efficacy of adenosin are better than those of dipyridamole. AdenoEX protocol provides good safety and patients tolerancy. In light of these benefits we recommend AdenoEX whenever possible. Dobutamine is the last pharmacological toll for MPS. [ABSTRACT FROM AUTHOR]

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results